N. Zealand Study Says Streptokinase A Risk For Some Pacific Islanders
This article was originally published in PharmAsia News
Executive Summary
New Zealand researchers determined that streptokinase, a common drug for treating heart attacks, is less effective in Pacific Islanders and Maori exposed to rheumatic fever bacteria